Search Result "ctl avidity"
Molecular Mechanisms and Biological Significance of CTL Avidity
Journal: Current HIV Research
Volume: 1 Issue: 3 Year: 2003 Page: 287-294
Author(s): James T. Snyder, Martha A. Alexander-Miller, Jay A. Berzofsky, Igor M. Belyakov
HIV-1-Specific Cytotoxic T Lymphocyte (CTL) Responses Against Immunodominant Optimal Epitopes Slow the Progression of AIDS in China
Journal: Current HIV Research
Volume: 6 Issue: 4 Year: 2008 Page: 335-350
Author(s): Song Zhai, Yan Zhuang, Yang Song, Shu Li, Dedong Huang, Wenzhen Kang, Xinhong Li, Qi Liao, Yanhou Liu, Zhongfang Zhao, Yichen Lu, Yongtao Sun
HIV-1 CTL-Based Vaccine Immunogen Selection: Antigen Diversity and Cellular Response Features
Journal: Current HIV Research
Volume: 5 Issue: 1 Year: 2007 Page: 97-107
Author(s): Fusheng Li, Helen Horton, Peter B. Gilbert, Juliana M. McElrath, Lawrence Corey, Steve G. Self
WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 787-797
Author(s): Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama
Lessons Learned from HIV Treatment Interruption: Safety, Correlates of Immune Control, and Drug Sparing
Journal: Current HIV Research
Volume: 1 Issue: 3 Year: 2003 Page: 329-342
Author(s): Livio Azzoni, Emmanouil Papasavvas, Luis J. Montaner
Recent Advances in T Cell Adoptive Immunotherapy of Cancer
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 1-13
Author(s): Li Zhang, Pouneh Dokouhaki
Neutralising Antibody, CTL and Dendritic Cell Responses to Hepatitis C Virus: A Preventative Vaccine Strategy
Journal: Current Drug Targets
Volume: 5 Issue: 1 Year: 2004 Page: 41-56
Author(s): Joseph Torresi, Mandvi Bharadwaj, David C. Jackson, Eric J. Gowans
Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 99-109
Author(s): G. Gross, A. Margalit
Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 1889-1903
Author(s): Clair S. Gricks, John G. Gribben
The GP120 Molecule of HIV-1 and its Interaction with T Cells
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2010 Page: 741-749
Author(s): V. Yoon, M. Fridkis-Hareli, S. Munisamy, J. Lee, D. Anastasiades, L. Stevceva